Consensus for 2025 revenue is $1.42B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALKS:
- Alkermes reports Q3 EPS 49c, consensus 39c
- Alkermes Advances in Sleep Disorder Treatment with ALKS 2680 Study
- Alkermes’ ALKS 2680 Study: A Promising Step in Sleep Disorder Treatment
- Alkermes’ ENLIGHTEN-Youth Study: A Potential Game-Changer in Pediatric Antipsychotic Treatment
- Alkermes’ Pediatric Study on OLZ/SAM: A Long-term Safety Evaluation